Pharmaids Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Pharmaids Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Pharmaids Pharmaceuticals Ltd.

09 Apr 2025

64.39

-2.42%

Corp. Note

Pharmaids Pharmaceuticals Ltd - 524572 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyPharmaids Pharmaceuticals Ltd 2CIN NO.L52520KA1989PLC173979 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Prasanna Subramanya Bhat Designation: Company Secretary and Compliance Officer EmailId: prasanna@pharmaids.com Name of the Chief Financial Officer: Balagangadhara B C Designation: Cheif Financial Officer EmailId: bg@pharmaids.com Date: 09/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Pharmaids Pharmaceuticals Ltd.

04 Apr 2025

64.39

-2.42%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended March 31, 2025.

pdf

Pharmaids Pharmaceuticals Ltd.

28 Mar 2025

64.39

-2.42%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Intimation Of Loan Agreement

BSE India

Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015 - Intimation of Loan agreement

pdf

Pharmaids Pharmaceuticals Ltd.

26 Mar 2025

64.39

-2.42%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform you that shareholders of the company approved the Re-appointment of Mr.Venu Madhava Kaparthy (DIN: 00021699) and Ms.Mini Manikantan (DIN: 09663184) as whole-time Directors and designated as Executive Directors.

pdf

Pharmaids Pharmaceuticals Ltd.

26 Mar 2025

64.39

-2.42%

AGM

Pharmaids Pharmaceuticals Ltd - 524572 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Further to our letter dated February 19, 2025, please find enclosed the Scrutinizer''s Report along with the proceedings of the Meeting held by way of postal ballot through remote e voting process.

pdf